Skip to main content
logo
Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
3.060
-0.240 (-7.27%)
Nov 5, 2026, 1:10 PM EST - Market open

Indaptus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
470510151247
Market Cap Growth
13512.64%-49.63%-31.58%21.38%-73.92%-
Enterprise Value
458-13-1-165
Last Close Price
3.302.9123.5849.2840.60159.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
38.661.622.571.220.501.30
P/TBV Ratio
44.571.622.571.220.501.30

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.020.010.000.01
Net Debt / Equity Ratio
-1.02-2.70-1.45-1.09-1.07-1.08
Net Debt / EBITDA Ratio
-0.430.370.811.775.04
Net Debt / FCF Ratio
0.790.570.460.982.023.45
Quick Ratio
18.771.381.714.827.708.50
Current Ratio
19.481.511.955.057.948.77
Return on Equity (ROE)
-318.04%-587.59%-187.53%-84.04%-47.32%-43.25%
Return on Assets (ROA)
-98.08%-148.91%-86.28%-47.63%-27.15%-22.81%
Return on Capital Employed (ROCE)
-129.90%-629.30%-389.50%-134.80%-60.50%-21.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-15.39%-409.13%-148.48%-104.31%-117.58%-16.51%
FCF Yield
-2.90%-290.89%-121.81%-90.66%-107.36%-24.18%
Buyback Yield / Dilution
-7142.37%-189.14%-11.36%-1.68%-101.98%-110.35%
SEC Filings: 10-K · 10-Q